{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:52:16Z","timestamp":1791341536861,"version":"4.3.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82188102"],"award-info":[{"award-number":["82188102"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303581"],"award-info":[{"award-number":["82303581"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303913"],"award-info":[{"award-number":["82303913"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2025-I2M-XHXX-054"],"award-info":[{"award-number":["2025-I2M-XHXX-054"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2025ZD0552500"],"award-info":[{"award-number":["2025ZD0552500"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2024ZD0533300"],"award-info":[{"award-number":["2024ZD0533300"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park","doi-asserted-by":"publisher","award":["Z221100007422011"],"award-info":[{"award-number":["Z221100007422011"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.canlet.2026.218838","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:41:46Z","timestamp":1789627306000},"page":"218838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["KEAP1 loss-of-function suppresses immunogenic ferroptosis and limits PD-1 blockade efficacy through an NRF2\u2013FSP1 pathway"],"prefix":"10.1016","volume":"660","author":[{"given":"Yuxin","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzhi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomi","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3714-3200","authenticated-orcid":false,"given":"Sijin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2531-5818","authenticated-orcid":false,"given":"Zijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-lin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0285-5403","authenticated-orcid":false,"given":"Jie","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.canlet.2026.218838_bib1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jtho.2021.10.013","article-title":"Diminished efficacy of programmed Death-(Ligand)1 inhibition in STK11- and KEAP1-Mutant lung adenocarcinoma is affected by KRAS mutation status","volume":"17","author":"Ricciuti","year":"2022","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"10.1016\/j.canlet.2026.218838_bib2","first-page":"395","article-title":"Clinical implications of KEAP1-NFE2L2 mutations in NSCLC","volume":"16","author":"Hellyer","year":"2021","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer"},{"issue":"10","key":"10.1016\/j.canlet.2026.218838_bib3","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.immuni.2023.08.014","article-title":"Dendritic cells as shepherds of T cell immunity in cancer","volume":"56","author":"Pittet","year":"2023","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.canlet.2026.218838_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012096","article-title":"Basic rules to respond to PD-1 blockade cancer immunotherapy","volume":"13","author":"Ribas","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"9","key":"10.1016\/j.canlet.2026.218838_bib5","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.ccell.2025.07.014","article-title":"DNASE1L3-expressing dendritic cells promote CD8+ T cell function and anti-PD-(L)1 therapy efficacy by degrading neutrophil extracellular traps","volume":"43","author":"Chen","year":"2025","journal-title":"Cancer Cell"},{"issue":"8071","key":"10.1016\/j.canlet.2026.218838_bib6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41586-025-09000-3","article-title":"STAT5 and STAT3 balance shapes dendritic cell function and tumour immunity","volume":"643","author":"Zhou","year":"2025","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.canlet.2026.218838_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113295","article-title":"KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance","volume":"42","author":"Zavitsanou","year":"2023","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.canlet.2026.218838_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012288","article-title":"Genetic drivers of tumor microenvironment and immunotherapy resistance in non-small cell lung cancer: the role of KEAP1, SMARCA4, and PTEN mutations","volume":"13","author":"Paredes","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2026.218838_bib9","article-title":"Tissue-specific properties of type 1 dendritic cells in lung cancer: implications for immunotherapy","volume":"13","author":"Rodriguez","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218838_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000337","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","volume":"8","author":"Galluzzi","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.canlet.2026.218838_bib11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting immunogenic cell stress and death for cancer therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.canlet.2026.218838_bib12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.canlet.2026.218838_bib13","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.immuni.2024.03.002","article-title":"DAMPs and DAMP-sensing receptors in inflammation and diseases","volume":"57","author":"Ma","year":"2024","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.canlet.2026.218838_bib14","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","article-title":"The KEAP1-NRF2 System: a thiol-based sensor-effector apparatus for maintaining redox homeostasis","volume":"98","author":"Yamamoto","year":"2018","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.canlet.2026.218838_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","article-title":"NRF2 and the hallmarks of cancer","volume":"34","author":"Rojo de la Vega","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218838_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101107","article-title":"NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis","volume":"23","author":"Dodson","year":"2019","journal-title":"Redox Biol."},{"issue":"9","key":"10.1016\/j.canlet.2026.218838_bib17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.molmed.2023.05.013","article-title":"FSP1: a key regulator of ferroptosis","volume":"29","author":"Li","year":"2023","journal-title":"Trends Mol. Med."},{"issue":"7784","key":"10.1016\/j.canlet.2026.218838_bib18","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.canlet.2026.218838_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41418-022-01096-8","article-title":"Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation","volume":"30","author":"M\u00fcller","year":"2023","journal-title":"Cell Death Differ."},{"issue":"8","key":"10.1016\/j.canlet.2026.218838_bib20","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41419-023-06070-x","article-title":"FSP1 confers ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma in NRF2-dependent and -independent manner","volume":"14","author":"Kim","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.canlet.2026.218838_bib21","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1038\/s41467-022-29905-1","article-title":"A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers","volume":"13","author":"Koppula","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.canlet.2026.218838_bib22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","article-title":"Tumor mutational load predicts survival after immunotherapy across multiple cancer types","volume":"51","author":"Samstein","year":"2019","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.canlet.2026.218838_bib23","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218838_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cytogfr.2023.08.004","article-title":"Ferroptosis in cancer immunity and immunotherapy: multifaceted interplay and clinical implications","volume":"75","author":"Zhai","year":"2024","journal-title":"Cytokine Growth Factor Rev."},{"issue":"4","key":"10.1016\/j.canlet.2026.218838_bib25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","article-title":"The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions","volume":"42","author":"Lei","year":"2024","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.canlet.2026.218838_bib26","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1093\/annonc\/mdy399","article-title":"Immunological differences between primary and metastatic breast cancer","volume":"29","author":"Szekely","year":"2018","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"issue":"6639","key":"10.1016\/j.canlet.2026.218838_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/science.abm5658","article-title":"Multimodal control of dendritic cell functions by nociceptors","volume":"379","author":"Han\u010d","year":"2023","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.canlet.2026.218838_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12974-023-02951-2","article-title":"iPSC-derived PSEN2 (N141I) astrocytes and microglia exhibit a primed inflammatory phenotype","volume":"21","author":"Sullivan","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.canlet.2026.218838_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107213","article-title":"Pro-inflammatory cytokines and CXC chemokines as game-changer in age-associated prostate cancer and ovarian cancer: insights from preclinical and clinical studies' outcomes","volume":"204","author":"Ullah","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.canlet.2026.218838_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010541","article-title":"Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancer","volume":"13","author":"Roudko","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218838_bib31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmgh.2023.03.001","article-title":"Ferroptosis suppressor protein 1 inhibition promotes tumor ferroptosis and anti-tumor immune responses in liver cancer","volume":"16","author":"Cheu","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.canlet.2026.218838_bib32","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1007\/s12094-023-03136-2","article-title":"Overexpression of ferroptosis-related genes FSP1 and CISD1 is related to prognosis and tumor immune infiltration in gastric cancer","volume":"25","author":"Zang","year":"2023","journal-title":"Clin. Transl. Oncol."},{"issue":"10","key":"10.1016\/j.canlet.2026.218838_bib33","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41585-024-00869-9","article-title":"Unlocking ferroptosis in prostate cancer \u2014 the road to novel therapies and imaging markers","volume":"21","author":"Cao","year":"2024","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218838_bib34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","article-title":"Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy","volume":"35","author":"Yang","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2026.218838_bib35","doi-asserted-by":"crossref","unstructured":"Castillo JG, Silveria S, Sauquet A, et al. Selective disruption of lipid peroxide homeostasis in intratumoral regulatory T cells by targeting FSP1 enhances cancer immunity. bioRxiv. Preprint posted online July 11, 2025:2025.07.06.663397. doi:10.1101\/2025.07.06.663397[Check first-page Not found in the Database, Check vol Not found in the Database, Check \"btl\" wrongly styled as \"atl\", Check \"stl\" wrongly styled as \"ebtl\", Check month present in end of the \"stl\"].","DOI":"10.1101\/2025.07.06.663397"},{"issue":"8","key":"10.1016\/j.canlet.2026.218838_bib36","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/cns.13654","article-title":"Ferroptosis-related gene signature predicts prognosis and immunotherapy in glioma","volume":"27","author":"Wan","year":"2021","journal-title":"CNS Neurosci. Ther."},{"issue":"17","key":"10.1016\/j.canlet.2026.218838_bib37","doi-asserted-by":"crossref","first-page":"9203","DOI":"10.3390\/ijms25179203","article-title":"Lipid peroxidation regulators GPX4 and FSP1 as prognostic markers and therapeutic targets in advanced gastric cancer","volume":"25","author":"Tamura","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.canlet.2026.218838_bib38","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/cac2.12363","article-title":"N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA","volume":"42","author":"Zheng","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.canlet.2026.218838_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.666025","article-title":"Identifying a ferroptosis-related gene signature for predicting biochemical recurrence of prostate cancer","volume":"9","author":"Lv","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.canlet.2026.218838_bib40","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41418-024-01263-z","article-title":"FSP1 inhibition enhances olaparib sensitivity in BRCA-proficient ovarian cancer patients via a nonferroptosis mechanism","volume":"31","author":"Miao","year":"2024","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.canlet.2026.218838_bib41","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1038\/s41467-022-31218-2","article-title":"Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity","volume":"13","author":"Wiernicki","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218838_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102833","article-title":"Loss of PERK function promotes ferroptosis by downregulating SLC7A11 (System Xc\u2212) in colorectal cancer","volume":"65","author":"Saini","year":"2023","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218838_bib43","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/emboj.2009.1","article-title":"Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death","volume":"28","author":"Panaretakis","year":"2009","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.canlet.2026.218838_bib44","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.2028","article-title":"Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors","volume":"15","author":"Ghiringhelli","year":"2009","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.canlet.2026.218838_bib45","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1158\/0008-5472.CAN-09-3566","article-title":"Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity","volume":"70","author":"Aymeric","year":"2010","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.canlet.2026.218838_bib46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nri.2016.4","article-title":"Purinergic regulation of the immune system","volume":"16","author":"Cekic","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218838_bib47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/cdd.2013.75","article-title":"Molecular mechanisms of ATP secretion during immunogenic cell death","volume":"21","author":"Martins","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2026.218838_bib48","article-title":"Dendritic cells as orchestrators of anticancer immunity and immunotherapy","volume":"7","author":"Heras-Murillo","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.canlet.2026.218838_bib49","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41568-019-0179-8","article-title":"Co-occurring genomic alterations in non-small cell lung cancer biology and therapy","volume":"19","author":"Skoulidis","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.canlet.2026.218838_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012710","article-title":"Tumor-secreted AGR2 induces dendritic cell dysfunction and impairs immunotherapy efficacy in LKB1-deficient cancer","volume":"13","author":"Yao","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2026.218838_bib51","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201900328","article-title":"Tumor-intrinsic response to IFN\u03b3 shapes the tumor microenvironment and anti-PD-1 response in NSCLC","volume":"2","author":"Bullock","year":"2019","journal-title":"Life Sci. Alliance"},{"issue":"17","key":"10.1016\/j.canlet.2026.218838_bib52","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1158\/0008-5472.CAN-18-0152","article-title":"Inhibition of Rspo-Lgr4 facilitates checkpoint blockade therapy by switching macrophage polarization","volume":"78","author":"Tan","year":"2018","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218838_bib53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1158\/2326-6066.CIR-16-0114","article-title":"Rational selection of Syngeneic preclinical tumor models for immunotherapeutic drug discovery","volume":"5","author":"Mosely","year":"2017","journal-title":"Cancer Immunol. Res."},{"issue":"6","key":"10.1016\/j.canlet.2026.218838_bib54","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.immuni.2023.05.011","article-title":"Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses","volume":"56","author":"Bayerl","year":"2023","journal-title":"Immunity"},{"issue":"42","key":"10.1016\/j.canlet.2026.218838_bib55","doi-asserted-by":"crossref","first-page":"17414","DOI":"10.1073\/pnas.1108945108","article-title":"Direct activation of antigen-presenting cells is required for CD8+ T-cell priming and tumor vaccination","volume":"108","author":"Kratky","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.canlet.2026.218838_bib56","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:23:52Z","timestamp":1791339832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526006026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":56,"alternative-id":["S0304383526006026"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218838","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KEAP1 loss-of-function suppresses immunogenic ferroptosis and limits PD-1 blockade efficacy through an NRF2\u2013FSP1 pathway","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218838","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218838"}}